ArticleMolecular therapy. Advances2026
Natural killer cell cryopreservation: Influence of composition, temperature, and granules on post-thaw survival and function.
Article in Molecular therapy. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Natural killer (NK) cells are promising off-the-shelf cancer immunotherapies, but their scalable deployment requires effective cryopreservation. Conventional dimethyl sulfoxide (DMSO)-based methods are associated with toxicity and persistent post-thaw functional impairment, and the mechanisms underlying NK cell cryoinjury remain incompletely understood. We investigated NK cell dysfunction following cryopreservation and evaluated DMSO-free cryoprotectant formulations as alternative strategies. DMSO-free formulations were optimized using a differential evolution algorithm. Cryopreserved NK-92 cells were assessed post-thaw for viability, recovery, proliferation, and cytotoxicity over 5 days. Raman cryomicroscopy and flow cytometry were used to characterize cytolytic granule localization and integrity during cooling and freezing. Pre-freezing chemical degranulation was performed to probe granule-mediated injury. Both DMSO-based and DMSO-free formulations had immediate post-thaw recovery and viability over 80% but had notable cell loss over 24 h. Although proliferation resumed by 48 h, expansion remained attenuated, and cytotoxic function was reduced by ≥ 20% and did not recover after 3-5 days. Imaging revealed temperature- and cryoprotective agent (CPA)-induced granule redistribution and destabilization. Pre-freeze degranulation improved short-term recovery and proliferation. These findings support cytolytic granule redistribution and destabilization as contributors to persistent NK cell dysfunction and may inform future cryopreservation strategies for NK cell therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.